
Hainan Shuangcheng Pharmaceuticals Co., Ltd.
SZSE:002693.SZ
7.54 (CNY) • At close November 27, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Hainan Shuangcheng Pharmaceuticals Co., Ltd. |
Symbool | 002693.SZ |
Munteenheid | CNY |
Prijs | 6.85 |
Beurswaarde | 2,850,860,400 |
Dividendpercentage | 0% |
52-weken bereik | 5.62 - 11.95 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Jianming Li |
Website | https://www.shuangchengmed.com |
An error occurred while fetching data.
Over Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Hainan Shuangcheng Pharmaceuticals Co., Ltd. researches, develops, manufactures, and markets synthesized peptide drugs and active pharmaceutical ingredients worldwide. It offers somatostatin, thymosin, clindamycin hydrochloride, thymopentin, L-carnitine, uranin hydrobromide, inosine, cyclophosphine adenosine, motidine, scopolamine, and sodium ferulate for injections, as well as vitamin B6. The company was founded in 2000 and
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CNY)
Cijfers zijn in miljoenen (CNY)